GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diagnosticos da America SA (BSP:DASA3) » Definitions » Piotroski F-Score

Diagnosticos da America (BSP:DASA3) Piotroski F-Score : 3 (As of Mar. 02, 2025)


View and export this data going back to 2004. Start your Free Trial

What is Diagnosticos da America Piotroski F-Score?

Warning Sign:

Piotroski F-Score of 3 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Diagnosticos da America has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Diagnosticos da America's Piotroski F-Score or its related term are showing as below:

BSP:DASA3' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 5   Max: 8
Current: 3

During the past 13 years, the highest Piotroski F-Score of Diagnosticos da America was 8. The lowest was 2. And the median was 5.


Diagnosticos da America Piotroski F-Score Historical Data

The historical data trend for Diagnosticos da America's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diagnosticos da America Piotroski F-Score Chart

Diagnosticos da America Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.00 3.00 5.00 3.00 2.00

Diagnosticos da America Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 2.00 2.00 2.00 3.00

Competitive Comparison of Diagnosticos da America's Piotroski F-Score

For the Diagnostics & Research subindustry, Diagnosticos da America's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diagnosticos da America's Piotroski F-Score Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Diagnosticos da America's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Diagnosticos da America's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep24) TTM:Last Year (Sep23) TTM:
Net Income was -537.359 + -175.955 + -104.623 + -87.489 = R$-905 Mil.
Cash Flow from Operations was -39.199 + -157.491 + -264.03 + 226.652 = R$-234 Mil.
Revenue was 3318.212 + 3727.992 + 3955.692 + 3969.21 = R$14,971 Mil.
Gross Profit was 638.276 + 1065.488 + 1139.81 + 1141.817 = R$3,985 Mil.
Average Total Assets from the begining of this year (Sep23)
to the end of this year (Sep24) was
(27093.749 + 26213.2 + 26935.2 + 28126.449 + 28290.129) / 5 = R$27331.7454 Mil.
Total Assets at the begining of this year (Sep23) was R$27,094 Mil.
Long-Term Debt & Capital Lease Obligation was R$12,056 Mil.
Total Current Assets was R$9,572 Mil.
Total Current Liabilities was R$5,794 Mil.
Net Income was -214.552 + -166.05 + -282.101 + -180.508 = R$-843 Mil.

Revenue was 3278.948 + 3534.07 + 3630.94 + 3769.014 = R$14,213 Mil.
Gross Profit was 842.123 + 1050.546 + 1084.466 + 1113.712 = R$4,091 Mil.
Average Total Assets from the begining of last year (Sep22)
to the end of last year (Sep23) was
(25122.552 + 26844.191 + 26319.119 + 27381.269 + 27093.749) / 5 = R$26552.176 Mil.
Total Assets at the begining of last year (Sep22) was R$25,123 Mil.
Long-Term Debt & Capital Lease Obligation was R$10,946 Mil.
Total Current Assets was R$8,144 Mil.
Total Current Liabilities was R$6,410 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Diagnosticos da America's current Net Income (TTM) was -905. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Diagnosticos da America's current Cash Flow from Operations (TTM) was -234. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Sep23)
=-905.426/27093.749
=-0.03341826

ROA (Last Year)=Net Income/Total Assets (Sep22)
=-843.211/25122.552
=-0.03356391

Diagnosticos da America's return on assets of this year was -0.03341826. Diagnosticos da America's return on assets of last year was -0.03356391. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Diagnosticos da America's current Net Income (TTM) was -905. Diagnosticos da America's current Cash Flow from Operations (TTM) was -234. ==> -234 > -905 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Sep24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep23 to Sep24
=12055.723/27331.7454
=0.44108866

Gearing (Last Year: Sep23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep22 to Sep23
=10946.385/26552.176
=0.41225943

Diagnosticos da America's gearing of this year was 0.44108866. Diagnosticos da America's gearing of last year was 0.41225943. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Sep24)=Total Current Assets/Total Current Liabilities
=9572.374/5793.666
=1.65221364

Current Ratio (Last Year: Sep23)=Total Current Assets/Total Current Liabilities
=8143.7/6409.635
=1.27054037

Diagnosticos da America's current ratio of this year was 1.65221364. Diagnosticos da America's current ratio of last year was 1.27054037. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Diagnosticos da America's number of shares in issue this year was 747.438. Diagnosticos da America's number of shares in issue last year was 746.96. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=3985.391/14971.106
=0.26620552

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=4090.847/14212.972
=0.28782488

Diagnosticos da America's gross margin of this year was 0.26620552. Diagnosticos da America's gross margin of last year was 0.28782488. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Sep23)
=14971.106/27093.749
=0.55256679

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Sep22)
=14212.972/25122.552
=0.56574555

Diagnosticos da America's asset turnover of this year was 0.55256679. Diagnosticos da America's asset turnover of last year was 0.56574555. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+1+0+1+0+0+0
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Diagnosticos da America has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

Diagnosticos da America  (BSP:DASA3) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Diagnosticos da America Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Diagnosticos da America's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Diagnosticos da America Business Description

Traded in Other Exchanges
N/A
Address
Avenida Jurua, 434, Alphaville, Barueri, SP, BRA, 06455-010
Diagnosticos da America SA operates as a medical diagnostics company in Brazil. The company offers clinical analysis, diagnostic imaging tests, and patient service centers. It has three operating segments. Outpatient care services and care coordination includes Diagnosis and health management, Hospitals and oncology include Medical and hospital services & Foreign operations include Diagnosis. The majority is from the Hospitals and oncology segment. Geographically, it operates in Brazil and South America (Argentina, Uruguay, Chile and Colombia).

Diagnosticos da America Headlines

No Headlines